[meetup] Thursday, April 18th: Biotech & The Opioid Crisis | New York, NY
We’re hosting a get together to network and have Dr. Jake Hutchins MD, Executive Medical Director at M Health Ambulatory Surgery Center, discuss the advancements made within the emerging field of non-opiate, peri-operative pain management. This event is hosted by Jim Segermark, CEO of InSitu Biologics.
We have a reserved space for up to 50 people. (this will sell out)
Network, Drinks, & Appetizers | Free
Thursday, April 18th | 5-8 PM
Staybridge Suites, Parlour Room – New York, NY
Your host, InSitu Biologics CEO James Segermark, will introduce Dr. Jacob Hutchins, who will present advancements in the emerging field of non-opiate, peri-operative pain management.
What to expect:
• Data and technology overview for non-opioid pain products (Dr. Hutchins)
• Learn about biotech Reg A+ investing (by. InSitu Biologics)
• Network with other investors and biotech industry peers
• Drinks & appetizers hosted by InSitu Biologics
JACOB HUTCHINS, MD, Executive Medical Director at M Health Ambulatory Surgery Center
Jake is a highly respected Anesthesiologist, pioneering the use of sustained release drugs for acute pain, regional anesthesia, and ambulatory anesthesia, all with an eye toward opioid reduction. Dr. Hutchins lectures around the globe on his experience and developments on the science.
JAMES SEGERMARK, CEO, InSitu Biologics, Inc.
Jim started his first of many companies, Vascular Dynamics, in 1989. Now, 30 years later, InSitu Biologics presents a rare opportunity to invest in an early stage company with a highly accomplished biotech executive known for bringing next generation technology to the marketplace through highly efficient management of the total enterprise.
For more information and to learn about Dr Hutchins or InSitu’s Biologics Technology, visit: www.insitubiologics.com
Jim Segermark, CEO of InSitu Biologics
1-651-338-4801 or email@example.com
Thursday, March 28th | 5-?? PM
D’Arcy’s Tavern – Bradley Beach, NJ*